$2.33 Billion is the total value of SABBY MANAGEMENT, LLC's 252 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | PRANA BIOTECHNOLOGY LTDput | $0 | – | -222 | -100.0% | -0.00% | – | |
| PRAN | Exit | PRANA BIOTECHNOLOGY LTDadr | $0 | – | -17,300 | -100.0% | -0.00% | – |
| EDAP | Exit | EDAP TMS SA -ADRadr | $0 | – | -23,200 | -100.0% | -0.00% | – |
| Exit | VIVUS INCput | $0 | – | -189 | -100.0% | -0.01% | – | |
| VVUS | Exit | VIVUS INC | $0 | – | -22,032 | -100.0% | -0.01% | – |
| Exit | DYAX CORPcall | $0 | – | -163 | -100.0% | -0.01% | – | |
| Exit | CORCEPT THERAPEUTICS INCcall | $0 | – | -400 | -100.0% | -0.01% | – | |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -18,274 | -100.0% | -0.01% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -5,126 | -100.0% | -0.01% | – |
| OMER | Exit | OMEROS CORP | $0 | – | -20,000 | -100.0% | -0.01% | – |
| ADMP | Exit | ADAMIS PHARMACEUTICALS CORP | $0 | – | -60,767 | -100.0% | -0.02% | – |
| Exit | MOMENTA PHARMACEUTICALS INCput | $0 | – | -382 | -100.0% | -0.02% | – | |
| Exit | AGENUS INCcall | $0 | – | -1,506 | -100.0% | -0.03% | – | |
| ZIOP | Exit | ZIOPHARM ONCOLOGY INC | $0 | – | -110,573 | -100.0% | -0.03% | – |
| ISR | Exit | ISORAY INC | $0 | – | -225,375 | -100.0% | -0.03% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -15,944 | -100.0% | -0.03% | – |
| Exit | ACELRX PHARMACEUTICALS INCcall | $0 | – | -469 | -100.0% | -0.03% | – | |
| AGEN | Exit | AGENUS INC | $0 | – | -185,830 | -100.0% | -0.03% | – |
| Exit | INSMED INCput | $0 | – | -305 | -100.0% | -0.03% | – | |
| Exit | CYTOKINETICS INCcall | $0 | – | -661 | -100.0% | -0.04% | – | |
| FURX | Exit | FURIEX PHARMACEUTICALS INC | $0 | – | -7,180 | -100.0% | -0.04% | – |
| Exit | ZIOPHARM ONCOLOGY INCput | $0 | – | -1,457 | -100.0% | -0.04% | – | |
| Exit | ALKERMES PLCput | $0 | – | -155 | -100.0% | -0.04% | – | |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALSwar | $0 | – | -377,908 | -100.0% | -0.04% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -54,000 | -100.0% | -0.04% | – |
| Exit | IDENIX PHARMACEUTICALS INCcall | $0 | – | -1,302 | -100.0% | -0.04% | – | |
| Exit | PRANA BIOTECHNOLOGY LTDcall | $0 | – | -2,994 | -100.0% | -0.05% | – | |
| Exit | PROTHENA CORPORATION PLCcall | $0 | – | -225 | -100.0% | -0.05% | – | |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -573,416 | -100.0% | -0.05% | – |
| Exit | EXACT SCIENCES CORPput | $0 | – | -655 | -100.0% | -0.05% | – | |
| Exit | TEKMIRA PHARMACEUTICALS CORPcall | $0 | – | -450 | -100.0% | -0.05% | – | |
| THRX | Exit | THERAVANCE INC | $0 | – | -34,531 | -100.0% | -0.06% | – |
| GEVA | Exit | SYNAGEVA BIOPHARMA CORP | $0 | – | -13,538 | -100.0% | -0.06% | – |
| Exit | AVANIR PHARMACEUTICALS INCput | $0 | – | -3,750 | -100.0% | -0.08% | – | |
| Exit | OPHTHOTECH CORPput | $0 | – | -400 | -100.0% | -0.08% | – | |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -34,420 | -100.0% | -0.09% | – |
| Exit | THERAVANCE INCput | $0 | – | -537 | -100.0% | -0.09% | – | |
| Exit | NEKTAR THERAPEUTICSput | $0 | – | -1,461 | -100.0% | -0.10% | – | |
| ENMD | Exit | ENTREMED INC | $0 | – | -1,065,217 | -100.0% | -0.11% | – |
| Exit | MOMENTA PHARMACEUTICALS INCcall | $0 | – | -1,729 | -100.0% | -0.11% | – | |
| DYAX | Exit | DYAX CORP | $0 | – | -230,000 | -100.0% | -0.12% | – |
| Exit | PFIZER INCput | $0 | – | -650 | -100.0% | -0.12% | – | |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -101,786 | -100.0% | -0.13% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -19,499 | -100.0% | -0.15% | – |
| Exit | MEDIVATION INCcall | $0 | – | -430 | -100.0% | -0.16% | – | |
| Exit | LIGAND PHARMACEUTICALS INCcall | $0 | – | -420 | -100.0% | -0.16% | – | |
| KERX | Exit | KERYX BIOPHARMACEUTICALS | $0 | – | -167,999 | -100.0% | -0.16% | – |
| TSRO | Exit | TESARO INC | $0 | – | -98,500 | -100.0% | -0.16% | – |
| Exit | BIODELIVERY SCIENCES INTERNATIONAL INCput | $0 | – | -3,952 | -100.0% | -0.19% | – | |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -38,630 | -100.0% | -0.26% | – |
| XBI | Exit | SPDR SERIES TRUSTtr | $0 | – | -43,745 | -100.0% | -0.35% | – |
| Exit | ISIS PHARMACEUTICALS INCcall | $0 | – | -1,584 | -100.0% | -0.38% | – | |
| BPTH | Exit | BIO PATH HOLDINGS INC | $0 | – | -3,313,600 | -100.0% | -0.49% | – |
| Exit | KERYX BIOPHARMACEUTICALSput | $0 | – | -5,238 | -100.0% | -0.50% | – | |
| Exit | ISIS PHARMACEUTICALS INCput | $0 | – | -2,078 | -100.0% | -0.50% | – | |
| Exit | ELI LILLYcall | $0 | – | -1,719 | -100.0% | -0.57% | – | |
| IWM | Exit | ISHARESput | $0 | – | -890 | -100.0% | -0.58% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -155,073 | -100.0% | -0.62% | – |
| Exit | MERCK & CO INCcall | $0 | – | -2,016 | -100.0% | -0.64% | – | |
| Exit | THERMO FISHER SCIENTIFIC INCcall | $0 | – | -1,100 | -100.0% | -0.74% | – | |
| Exit | PFIZER INCcall | $0 | – | -4,301 | -100.0% | -0.78% | – | |
| Exit | PHARMACYCLICS INCcall | $0 | – | -1,500 | -100.0% | -0.84% | – | |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -1,338 | -100.0% | -1.40% | – |
| Exit | APPLE INCcall | $0 | – | -579 | -100.0% | -1.74% | – | |
| Exit | APPLE INCput | $0 | – | -579 | -100.0% | -1.74% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.